| HOME >> BIOLOGY >> TECHNOLOGY |
$
335,649$
317,862$
17,7875.6%(2.6%)1.1%7.1%Net CAG RevenueThree
Months
Ended June
30, 2012Three
Months Ended June 30, 2011DollarChangePercentageChangePercentageChange fromCurrency (1)PercentageChange fromAcquisitions (2)Organic Revenue Growth(3) Instruments and consumables
$
104,243$
98,603$
5,6405.7%(2.8%)-8.5%Rapid assay products45,57744,1931,3843.1%(1.1%)-4.2%Reference laboratory diagnostic and consulting services 106,38599,0877,2987.4%(3.0%)3.6%6.8%Practice management and digital imaging systems22,08917,8514,23823.7%(0.4%)-24.1%Net CAG revenue
$
278,294$
259,734$
18,5607.1%(2.5%)1.4%8.2%(1) The percentage change from currency is a non-U.S. GAAP measure. It represents the percentage change in revenue resulting from the difference between the average exchange rates during the three months ended June 30, 2012 and the same period of the prior year applied to foreign currency denominated revenues for the three months ended June 30, 2012.
(2) The percentage change from acquisitions is a non-U.S. GAAP measure. It represents the percentage change in revenue during the three months ended June 30, 2012 compared to the three months ended June 30, 2011 attributed to acquisitions subsequent to March 31, 2011.
(3) Organic revenue growth is a non-U.S. GAAP measure and represents the percentage change in revenue during the three months ended June 30, 2012 compared to the three months ended June 30, 2011 net of acquisitions and the effect of changes in foreign currency exchange rates.
IDEXX Laboratories, Inc. and SubsidiariesRevenues and Revenue Growth Analysis by Product and Service CategoriesAmounts in thousands (Unaudited)Net RevenueSix Months Ended June 30, 2012Six Months Ended June 30, 2011DollarChangePercentageChangePercentageChange fromCurrency (1)
| SOURCE IDEXX Laboratories, Inc. Copyright©2012 PR Newswire. All rights reserved |